Cutaquig 165 mg/mL

Cutaquig 165 mg/mL is a subcutaneous immunoglobulin G solution used to treat immune deficiencies. This product, manufactured by Pfizer, helps support the immune system in individuals with primary immunodeficiency.

Cutaquig 165 mg/mL is primarily used to replace antibodies in people with primary immunodeficiency. This condition occurs when the body does not produce enough antibodies to fight infections. The solution is administered subcutaneously to provide ongoing immune support. People often ask, 'What is Cutaquig used for?' It is designed to help prevent infections in those with weakened immune systems.

Common effects of Cutaquig 165 mg/mL may include redness, swelling, or itching at the injection site. Some individuals might experience mild flu-like symptoms such as headache or fatigue. These effects are generally temporary and should subside over time.

Cutaquig 165 mg/mL should be handled with care. Ensure the solution is clear and colorless before use. Always follow the instructions provided by your healthcare professional for proper administration. Store the vials as directed to maintain their efficacy.

Cutaquig 165 mg/mL may interact with certain medications or substances. It is important to discuss all current medications with your healthcare provider before starting treatment. Avoid mixing with other medications in the same syringe unless directed by a healthcare professional.